Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/41083
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorDEWACHTER, Ilse
dc.contributor.advisorBEEKEN, Jolien
dc.contributor.authorLuykx, Anaïs
dc.date.accessioned2023-09-21T07:48:58Z-
dc.date.available2023-09-21T07:48:58Z-
dc.date.issued2023
dc.identifier.urihttp://hdl.handle.net/1942/41083-
dc.format.mimetypeApplication/pdf
dc.languageen
dc.publishertUL
dc.titleValidation of preclinical cellular models to screen the effectiveness of drugs directed to slow down Alzheimer’s and Parkinson’s disease progression
dc.typeTheses and Dissertations
local.bibliographicCitation.jcatT2
dc.description.notesMaster of Biomedical Sciences-Molecular Mechanisms in Health and Disease
local.type.specifiedMaster thesis
item.accessRightsOpen Access-
item.fullcitationLuykx, Anaïs (2023) Validation of preclinical cellular models to screen the effectiveness of drugs directed to slow down Alzheimer’s and Parkinson’s disease progression.-
item.fulltextWith Fulltext-
item.contributorLuykx, Anaïs-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
11937820-d149-4ebc-b650-1f6e13f1a1dc.pdf1.9 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.